Description: A review of a pamphlet which described the amendments to the Social Security Act in 1977.

Description: An overview of the formation of the Committee of Professional Associations on Federal Statistics, initiated by the Joint Ad Hoc Committee on Government Statistics, in response to the need for statistical advisory committees to government agencies to promote better data collection and dissemination, contracting, forms clearance, planning, coordination, monitoring, staffing, and strengthening of agency functions.

Description: Article Confidentiality Of Federal Statistics by Johansen in The Actuary, June 1979, Volume 13, Number 6

Description: This article is the testimony of the author to the New York State Assembly Standing Committee on Insurance expressing his views about a proposed law to allow a domestic mutual life insurer to reorganize as a stock company that is owned by a mutual holding company.

Description: In 2020, the Korean insurance regulator, Financial Services Commission (FSC), introduced a coinsurance structure allowing for full risk transfer—including investment risk, interest rate risk, insurance risk, and policyholder lapse risk—as a permitted practice. Expanding use of coinsurance in the Korean insurance market brings a suite of potential benefits to Korean insurance companies including increased financial flexibility, options to improve policyholder protection and shareholder value through optimization of business strategies. As such, FSC’s initiative and intention to introduce coinsurance opportunities to the market is commendable.

Description: The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks off the process of changing the specialty drug marketplace in the United States. The expectation of the full impact of this big event is very hopeful, but there is still uncertainty several months after its beginning. Humira is the highest-selling drug in the world and has been since 2013 (Figure 1)—except for when COVID-19 projects temporarily surpassed it. The world is eagerly awaiting the launch of multiple biosimilar drugs to compete with Humira and hopefully bring more competitive pricing to the benefit of payers and patients everywhere.

Description: A discussion of the many developments affecting taxation of life insurance companies and products.

Description: The New York State Insurance Department has appointed a committee to redraft and modernize its agent compensation law to account for new forms of insurance. The New York law, which has had a major effect on agent compensation since the early 1900s protects consumers from excessive expenses and generally has worked well.

Description: Article on the history of the Long Term Care Discussion Group, a Washington DC-based venue for discussing long-term care and related issues for over 20 years.

Description: Discusses the recent firing of the Social Security Commissioner and the president's legal authority to do so.